Quantification of sofosbuvir and ledipasvir in human plasma by UPLC–MS/MS method: Application to fasting and fed bioequivalence studies

Mamdouh R. Rezk1, Ehab R. Bendas2, Emad B. Basalious3, Iman A. Karim4
1Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, 11562, Cairo, Egypt
2Clinical Pharmacy Department, Faculty of Pharmaceutical Sciences & Pharmaceutical Industries, Future University in Egypt, Egypt
3Pharmaceutics and Industrial Pharmacy Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, 11562, Cairo, Egypt
4Advanced Research Center (ARC), Nasr City, Cairo, Egypt

Tài liệu tham khảo

Afdhal, 2014, N. Engl. J. Med., 370, 1483, 10.1056/NEJMoa1316366

Afdhal, 2014, N. Engl. J. Med., 370, 1889, 10.1056/NEJMoa1402454

Rezk, 2016, Biomed. Chromatogr.

Website, http://apps.who.int/prequal/info_applicants/BE/2015/Sofosbuvir_BE25March2015.pdf (accessed 18.06.15.)

FDA, Guidance for industry: bioanalytical method validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CV) (2001).